Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Global Fund List


Published on

  • Be the first to comment

  • Be the first to like this

Global Fund List

  1. 1. The Global Fund List for ARV, TB and Malaria Kuala Lumpur, Malaysia, November 2009
  2. 2. Outline of the Session <ul><li>Background </li></ul><ul><li>Global Fund Classification </li></ul><ul><ul><li>Option “A” </li></ul></ul><ul><ul><li>Option “B” </li></ul></ul><ul><ul><li>Option “ERP Reviewed” </li></ul></ul><ul><li>SRA and GMP </li></ul><ul><li>Procurement selection </li></ul><ul><li>Required Documentations for listing </li></ul><ul><li>6. Comments/ Observation </li></ul>
  3. 3. Introduction <ul><li>The list is an overview of pharmaceutical products subject to the Global Fund Quality Assurance Policy that are listed in National and/or WHO standard treatment guidelines ; </li></ul><ul><li>Products are classified according to the various options (A, B, and ERP reviewed) defined as per the Global Fund Quality Assurance Policy; </li></ul><ul><li>The list is developed as a tool to assist Principal Recipients (PR) to identify the status of finished pharmaceutical products (FPP; </li></ul><ul><li>The List is updated regularly (usually monthly), based on the information received by the Global Fund ; </li></ul><ul><li>The list is not “ Not Global Fund Approved List” </li></ul>
  4. 4. Product Classification <ul><li>Option A - products are prequalified by the WHO Prequalification Programme; </li></ul><ul><li>Option B - products are approved or authorized for use by a Stringent Regulatory Authority (SRA) ; </li></ul><ul><li>Option ERP Reviewed - reviewed by Expert Review Panel (ERP) upon potential quality risk/benefit assessment of the product which are not yet WHO-prequalified or SRA-authorized.   </li></ul><ul><li>Permitted for time-limited ( 12 months) use based on advice by the ERP; </li></ul>
  5. 5. Stringent Regulatory Authority (SRA) <ul><li>Members, Observers and Associates of ICH; </li></ul><ul><ul><li>MEMBERS : European Union Members, Japan, United States; </li></ul></ul><ul><ul><li>OBSERVERS : European Free Trade Association (EFTA) represented by Swiss Medic of Switzerland, and Health Canada; </li></ul></ul><ul><ul><li>ASSOCIATES: through mutual recognition agreements- Australia, Norway, Iceland and Liechtenstein; </li></ul></ul><ul><li>And any other entities which may be updated from time to time; </li></ul>
  6. 6. Good Manufacturing Practice (GMP) <ul><li>Member countries of PIC/S; </li></ul><ul><ul><li>Argentina (since January, 2008), </li></ul></ul><ul><ul><li>Austria, Belgium, Cyprus (since July, 2008), Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Malaysia, Malta (since January, 2008), Netherlands; Norway, Poland, Portugal, Romania, Slovak Republic, Spain, Sweden; Switzerland, United Kingdom; </li></ul></ul><ul><ul><li>South Africa (since July, 2007); </li></ul></ul><ul><ul><li>Malaysia, Singapore; </li></ul></ul><ul><ul><li>Australia , Canada; </li></ul></ul>
  7. 7. Documentations Requirement <ul><ul><li>Option “ A ” : </li></ul></ul><ul><ul><ul><ul><li>WHO Prequalification Programme publishes the list of prequalified products which are considered as “ A” and updated accordingly in the GF List; </li></ul></ul></ul></ul><ul><ul><li>Option “B” : </li></ul></ul><ul><ul><ul><ul><li>Copy of approval, or registration certificate or marketing authorization from the Stringent Regulatory Authority ( SRA); </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Copy of GMP (Good Manufacturing Practice) certificate issued by a member of ICH/PICs or WHO Prequalification; </li></ul></ul></ul></ul><ul><ul><li>ERP Reviewed : </li></ul></ul><ul><ul><ul><ul><li>Decision by GF Secretariat based on Advice from ERP upon review of product dossiers; </li></ul></ul></ul></ul>
  8. 8. Product Selection <ul><li>More than two A or B classified product; </li></ul><ul><li>Less than two A or B classified product; </li></ul><ul><li>ERP Reviewed product- </li></ul><ul><ul><li>Notification </li></ul></ul><ul><ul><li>No Objection </li></ul></ul><ul><ul><li>QC testing </li></ul></ul>
  9. 9. Temporary provision-20 th Board Decision, 2009 <ul><li>Only for certain multi source FPPs for Malaria & 1 st line TB; </li></ul><ul><li>Valid until only December 31, 2010 ; </li></ul><ul><li>No FPP classified as A or B or ERP reviewed available; </li></ul><ul><li>Manufactured at GMP compliant site; </li></ul><ul><li>Selected for procurement by relevant UN Agencies ; </li></ul><ul><li>Notification process- No Objection-QC testing; </li></ul>
  10. 10. QA Policy Compliance/Monitoring <ul><li>Procurement Reporting by PR; </li></ul><ul><li>PQR database -Product information; </li></ul><ul><li>Monthly and Quarterly QA Compliance Report ; </li></ul><ul><ul><li>Non Compliance Level 1 </li></ul></ul><ul><ul><li>Non Compliance Level 2 </li></ul></ul>
  11. 11. Comment-Manufacturer <ul><li>Always check the updated version of the GF List to make sure your qualified products are included; </li></ul><ul><li>Update the Secretariat right the way for any </li></ul><ul><ul><li>new approval </li></ul></ul><ul><ul><li>modification of regulatory status; </li></ul></ul><ul><ul><li>change of manufacturing site; </li></ul></ul><ul><li>Provide packaging information; </li></ul>
  12. 12. Global Fund List on the Web page <ul><li>The Global Fund list for ARV, TB and Malaria is available on </li></ul><ul><li>We strongly encourage users to visit the webpage and make sure to use the most recent version when considering the procurement options. </li></ul><ul><li>For any questions or clarifications, please feel free to contact us at [email_address] ; </li></ul>
  13. 13. Global Fund List on the webpage
  14. 14. Questions <ul><li>Terima kasih!!!! </li></ul>